Mucinex On Target In DayQuil Comparison Despite Disparate Formulations
This article was originally published in The Tan Sheet
Executive Summary
RB’s ad comparing Mucinex Fast-Max Liquid Gels to Procter & Gamble’s DayQuil LiquiCaps is not misleading because, even though they have different formulations, the products compared were clearly identified, the National Advertising Division says.
You may also be interested in...
Mucinex Fast-Max Advertising Claim Exceeds Indications In NAD Review
Review was second in two years by the Council of Better Business Bureaus' National Advertising Division of a challenge to Reckitt Benckiser ad claims for its Mucinex cough/cold line made by Procter & Gamble, which markets competing products including Vicks NyQuil and DayQuil brands.
Mucinex Fast-Max Advertising Claim Exceeds Indications In NAD Review
Review was second in two years by the Council of Better Business Bureaus' National Advertising Division of a challenge to Reckitt Benckiser ad claims for its Mucinex cough/cold line made by Procter & Gamble, which markets competing products including Vicks NyQuil and DayQuil brands.
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value of $2.85bn to reduce debt and streamline its business to three segments, including scents.